Lithea’s technology showcased at ORS 2025 Annual meeting in Phoenix, Arizona, US

We are excited to share that our research team at Lund University recently attended the Orthopaedic Research Society’s (ORS) Annual Meeting in Phoenix, Arizona, February 2025, where they presented groundbreaking advancements in musculoskeletal oncology and locally delivered drugs for solid tumours.

At ORS 2025, three peer-reviewed abstracts, references below, were presented of which two as poster presentations and one as a podium presentation all focused on showcasing our latest research on targeted drug delivery systems designed to improve treatment efficacy while minimizing systemic side effects. Our innovative approach focuses on localized therapies that enhance tumour control, paving the way for improved patient outcomes in bone cancer.

Participating in ORS 2025 reflects the scientific rigor that Lithea’s platform technology is based on and showcases our ongoing commitment to transforming cancer treatment through precision medicine and innovation. We are proud of our researchers for their dedication and grateful for the opportunity to engage with leading experts in the field.

• Evaluating Cytotoxicity of Doxorubicn Released from an Iohexol Containing Calcium Sulfate/Hydroxyapatite Biomaterial Against Tumor Cells In-Vitro
  Hadis Alidadi1, Lars Lidgren1, Magnus Tägil1, Deepak Bushan Raina1
  1Lund University, Sweden.
• Pharmacokinetics and Safety of Locally Delivered Doxorubicin from a Ceramic Biomaterial: An Intraosseous Implantation Study in Sheep Mathias Lidgren1, Vetra Markeviciute2, Laureen Vanille Marsault3, Tova Corbascio1, Hadis Alidadi1, Jintian Huang1, Jacob Engellau1, Lars Lidgren1, Magnus Tägil1, Deepak Bushan Raina1
• Controlled Intra-tumoral Delivery of Doxorubicin from a Ceramic Biomaterial for Treatment of an Orthotopic Osteosarcoma in Mice Tova Corbascio, Hadis Alidadi, Jintian Huang, Mathias Lidgren, Jacob Engellau, Lars Lidgren, Magnus Tägil, Deepak Bushan Raina Institution: Department of Orthopedics, Clinical Sciences, BMC Lund, Sweden

Stay tuned as we continue to push the boundaries of oncology and orthopaedic science!